{
    "clinical_study": {
        "@rank": "15007", 
        "arm_group": [
            {
                "arm_group_label": "L. reuteri DSM 17938", 
                "arm_group_type": "Active Comparator", 
                "description": "Lactobacillus reuteri DSM 17938,10(9)CFU/daily (for the duration of hospitalization)\nARM I: Rotavirus vaccinated patients\nARM II: Non-rotavirus vaccinated patients"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo consists of an identical formulation in all respects except that the live probiotic bacteria were excluded\nfor the duration of hospitalization"
            }
        ], 
        "brief_summary": {
            "textblock": "AIM: To determine the efficacy of Lactobacillus reuteri DSM 17938 at a dose of 10(9) CFU for\n      the prevention of nosocomial diarrhea.\n\n      TRIAL DESIGN: Double-blind, placebo controlled RCT. INTERVENTION: L reuteri DSM 17938 in a\n      daily dose of 10(9) CFU. PRIMARY OUTCOME: Nosocomial diarrhoea (3 or more loose or watery\n      stools in a 24 h that will occur more than 72 h after admission)."
        }, 
        "brief_title": "Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diarrhea", 
        "condition_browse": {
            "mesh_term": "Diarrhea"
        }, 
        "detailed_description": {
            "textblock": "Nosocomial diarrhea is a common problem in hospitalized children. Previously, it has been\n      documented that the administration of L reuteri DSM 17938 at a dose of 10(8) colony forming\n      units (CFU) compared with placebo had no effect on the overall incidence of nosocomial\n      diarrhea (Wanke & Szajewska, J Pediatr 2012). Whether higher doses of L reuteri DSM 17938\n      have such effects needs to be substantiated in further randomized trials."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children aged 1-48 mo admitted to the hospital for reasons other than diarrhea\n\n          -  Signed informed consent.\n\n        Exclusion Criteria:\n\n          -  Acute gastroenteritis within 3 days before admission\n\n          -  Symptoms other than diarrhea suggesting gastroenteritis\n\n          -  Use of probiotics within 7 days before admission\n\n          -  Immunodeficiency disorders\n\n          -  Breastfeeding >50%\n\n          -  Underlying gastrointestinal tract disorder\n\n          -  Malnutrition (weight/high <3pc)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "48 Months", 
            "minimum_age": "1 Month"
        }, 
        "enrollment": {
            "#text": "106", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01968408", 
            "org_study_id": "KB/125/2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "L. reuteri DSM 17938", 
                "description": "10(9) CFU/daily", 
                "intervention_name": "Lactobacillus reuteri DSM 17938", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "nosocomial diarrhea", 
            "Lactobacillus reuteri DSM 17938", 
            "rotavirus diarrhea", 
            "probiotics"
        ], 
        "lastchanged_date": "October 18, 2013", 
        "location": {
            "contact": {
                "email": "magdalena.urb@gmail.com", 
                "last_name": "Magdalena Urba\u0144ska, MD", 
                "phone": "+48224523274"
            }, 
            "contact_backup": {
                "email": "hania@ipgate.pl", 
                "last_name": "Hanna Szajewska, MD, Profesor", 
                "phone": "+48224523309"
            }, 
            "facility": {
                "address": {
                    "city": "Warsaw", 
                    "country": "Poland", 
                    "zip": "01-410"
                }, 
                "name": "Department of Pediatrics, Medical University of Warsaw"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effectiveness of Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children: a Randomized, Double-blind Placebo Controlled Trial", 
        "overall_contact": {
            "email": "magdalena.urb@gmail.com", 
            "last_name": "Magdalena Urba\u0144ska, MD", 
            "phone": "+48224523274"
        }, 
        "overall_contact_backup": {
            "email": "hania@ipgate.pl", 
            "last_name": "Hanna Szajewska, Proffesor", 
            "phone": "+48224523309"
        }, 
        "overall_official": {
            "affiliation": "Medical University of Warsaw", 
            "last_name": "Hanna Szajewska, MD, Profesor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Poland: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence of nosocomial diarrhea (defined as the passage of 3 or more loose or watery stools in a 24-hour period that will occur more than 72 hours after admission)", 
            "safety_issue": "No", 
            "time_frame": "Any time starting 72 h after admission"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01968408"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Warsaw", 
            "investigator_full_name": "Hanna Szajewska", 
            "investigator_title": "Proffesor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of diarrhea- passage of 3 or more loose or watery stools in a 24-h period", 
                "safety_issue": "No", 
                "time_frame": "from the time of admission to the time of discharge of the hospital-expected average 3-5 days"
            }, 
            {
                "measure": "Duration of diarrhea (ie, time till the last loose or watery stool from the onset of diarrhea)", 
                "safety_issue": "No", 
                "time_frame": "during hospitalisation (expected average 3-5 days) and 72 h after discharge"
            }, 
            {
                "measure": "Need and the length of intravenous rehydration due to diarrhea", 
                "safety_issue": "No", 
                "time_frame": "During the hospitalization-expected average 3-5 days"
            }, 
            {
                "measure": "Prolongation of the hospitalization due to nosocomial diarrhea", 
                "safety_issue": "No", 
                "time_frame": "during the hospitalization-expected average 3-5 days"
            }, 
            {
                "description": "Positive test for rotavirus or antigen in the stool sample", 
                "measure": "Incidence of rotavirus diarrhea (ie, detection of rotavirus or antigen in the stools)", 
                "safety_issue": "No", 
                "time_frame": "72 hours after admission to the hospital to 72 hours after discharge"
            }, 
            {
                "measure": "Incidence of chronic diarrhea- lasting more than 14 days", 
                "safety_issue": "No", 
                "time_frame": "untill 14 days after onset of diarrhea"
            }, 
            {
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "During hospitalisation-expected average 3-5 days"
            }, 
            {
                "measure": "Adverse effects", 
                "safety_issue": "Yes", 
                "time_frame": "During hospitalisation (expected average 3-5 days) plus 72 h after discharge"
            }
        ], 
        "source": "Medical University of Warsaw", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Warsaw", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}